BioCentury
ARTICLE | Company News

Dance Biopharm, Harmony Asset deal

October 21, 2013 7:00 AM UTC

Dance and Harmony formed a JV to develop and commercialize Dance's Adagio inhaled insulin in China and other Asian countries, excluding Japan. Harmony, which will have majority ownership of the JV, w...